Global Biotech Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	216 Pages	TechNavio	December, 2024	INF19463446

Best Price Guarantee
Price	from $2,500
Length	216 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463446

Biotech Market 2025-2029

The biotech market is forecasted to grow by USD 805.6 bn during 2024-2029, accelerating at a CAGR of 12.4% during the forecast period. The report on the biotech market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing innovation by market vendors, prevalence of chronic diseases, and growing research for novel therapies.

Technavio's biotech market is segmented as below:

By Product

Biologics
Therapeutics
Diagnostics
Industrial biotechnology
Others

By Type

Red biotechnology
White biotechnology
Green biotechnology
Grey biotechnology
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing investment by market vendors as one of the prime reasons driving the biotech market growth during the next few years. Also, inorganic growth strategies by market vendors and growing production facilities by market vendors will lead to sizable demand in the market.

The report on the biotech market covers the following areas:

Biotech Market sizing
Biotech Market forecast
Biotech Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biotech market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, BeiGene Ltd., BioMarin Pharmaceutical Inc., BioNTech SE, CSL Ltd., F. Hoffmann La Roche Ltd., Genmab AS, Gilead Sciences Inc., Johnson and Johnson Inc., Moderna Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc.. Also, the biotech market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth."

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Biotech Market 2019 - 2023; Historic Market Size - Data Table on Global Biotech Market 2019 - 2023 ($ billion); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.3 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on the Global Biotech Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Biologics - Market size and forecast 2024-2029; Chart on Biologics - Market size and forecast 2024-2029 ($ billion); Data Table on Biologics - Market size and forecast 2024-2029 ($ billion); Chart on Biologics - Year-over-year growth 2024-2029 (%); Data Table on Biologics - Year-over-year growth 2024-2029 (%); 8.4 Therapeutics - Market size and forecast 2024-2029; Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion); Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion); Chart on Therapeutics - Year-over-year growth 2024-2029 (%); Data Table on Therapeutics - Year-over-year growth 2024-2029 (%); 8.5 Diagnostics - Market size and forecast 2024-2029; Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion); Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion); Chart on Diagnostics - Year-over-year growth 2024-2029 (%); Data Table on Diagnostics - Year-over-year growth 2024-2029 (%); 8.6 Industrial biotechnology - Market size and forecast 2024-2029; Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Type: 9.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 9.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 9.3 Red biotechnology - Market size and forecast 2024-2029; Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Red biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%); 9.4 White biotechnology - Market size and forecast 2024-2029; Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on White biotechnology - Year-over-year growth 2024-2029 (%); Data Table on White biotechnology - Year-over-year growth 2024-2029 (%); 9.5 Green biotechnology - Market size and forecast 2024-2029; Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Green biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%); 9.6 Grey biotechnology - Market size and forecast 2024-2029; Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%); Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%); 9.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.8 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.10 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.12 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.13 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.14 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.15 Switzerland - Market size and forecast 2024-2029; Chart on Switzerland - Market size and forecast 2024-2029 ($ billion); Data Table on Switzerland - Market size and forecast 2024-2029 ($ billion); Chart on Switzerland - Year-over-year growth 2024-2029 (%); Data Table on Switzerland - Year-over-year growth 2024-2029 (%); 11.16 Sweden - Market size and forecast 2024-2029; Chart on Sweden - Market size and forecast 2024-2029 ($ billion); Data Table on Sweden - Market size and forecast 2024-2029 ($ billion); Chart on Sweden - Year-over-year growth 2024-2029 (%); Data Table on Sweden - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 14.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 14.6 BeiGene Ltd.; BeiGene Ltd. - Overview; BeiGene Ltd. - Business segments; BeiGene Ltd. - Key offerings; BeiGene Ltd. - Segment focus; SWOT; 14.7 BioMarin Pharmaceutical Inc.; BioMarin Pharmaceutical Inc. - Overview; BioMarin Pharmaceutical Inc. - Product / Service; BioMarin Pharmaceutical Inc. - Key offerings; SWOT; 14.8 BioNTech SE; BioNTech SE - Overview; BioNTech SE - Product / Service; BioNTech SE - Key offerings; SWOT; 14.9 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 14.10 Genmab AS; Genmab AS - Overview; Genmab AS - Product / Service; Genmab AS - Key offerings; SWOT; 14.11 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; SWOT; 14.12 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 14.13 Moderna Inc.; Moderna Inc. - Overview; Moderna Inc. - Product / Service; Moderna Inc. - Key offerings; SWOT; 14.14 Novo Nordisk AS; Novo Nordisk AS - Overview; Novo Nordisk AS - Business segments; Novo Nordisk AS - Key offerings; Novo Nordisk AS - Segment focus; SWOT; 14.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.16 Regeneron Pharmaceuticals Inc.; Regeneron Pharmaceuticals Inc. - Overview; Regeneron Pharmaceuticals Inc. - Product / Service; Regeneron Pharmaceuticals Inc. - Key offerings; SWOT; 14.17 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT; 14.18 Vertex Pharmaceuticals Inc.; Vertex Pharmaceuticals Inc. - Overview; Vertex Pharmaceuticals Inc. - Product / Service; Vertex Pharmaceuticals Inc. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Biotech Market 2019 - 2023 ($ billion); Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Product - Market share 2024-2029 (%); Exhibits37: Data Table on Product - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Product; Exhibits39: Data Table on Comparison by Product; Exhibits40: Chart on Biologics - Market size and forecast 2024-2029 ($ billion); Exhibits41: Data Table on Biologics - Market size and forecast 2024-2029 ($ billion); Exhibits42: Chart on Biologics - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Biologics - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Therapeutics - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on Therapeutics - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on Therapeutics - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Therapeutics - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits49: Data Table on Diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits50: Chart on Diagnostics - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Diagnostics - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits53: Data Table on Industrial biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits54: Chart on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on Industrial biotechnology - Year-over-year growth 2024-2029 (%); Exhibits56: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits57: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits58: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits59: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits60: Market opportunity by Product ($ billion); Exhibits61: Data Table on Market opportunity by Product ($ billion); Exhibits62: Chart on Type - Market share 2024-2029 (%); Exhibits63: Data Table on Type - Market share 2024-2029 (%); Exhibits64: Chart on Comparison by Type; Exhibits65: Data Table on Comparison by Type; Exhibits66: Chart on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits67: Data Table on Red biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits68: Chart on Red biotechnology - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Red biotechnology - Year-over-year growth 2024-2029 (%); Exhibits70: Chart on White biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits71: Data Table on White biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits72: Chart on White biotechnology - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on White biotechnology - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits75: Data Table on Green biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits76: Chart on Green biotechnology - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Green biotechnology - Year-over-year growth 2024-2029 (%); Exhibits78: Chart on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits79: Data Table on Grey biotechnology - Market size and forecast 2024-2029 ($ billion); Exhibits80: Chart on Grey biotechnology - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Grey biotechnology - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits83: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits84: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits86: Market opportunity by Type ($ billion); Exhibits87: Data Table on Market opportunity by Type ($ billion); Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits91: Chart on Geographic comparison; Exhibits92: Data Table on Geographic comparison; Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits134: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits135: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on Switzerland - Market size and forecast 2024-2029 ($ billion); Exhibits142: Data Table on Switzerland - Market size and forecast 2024-2029 ($ billion); Exhibits143: Chart on Switzerland - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on Switzerland - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on Sweden - Market size and forecast 2024-2029 ($ billion); Exhibits146: Data Table on Sweden - Market size and forecast 2024-2029 ($ billion); Exhibits147: Chart on Sweden - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on Sweden - Year-over-year growth 2024-2029 (%); Exhibits149: Market opportunity By Geographical Landscape ($ billion); Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits151: Impact of drivers and challenges in 2024 and 2029; Exhibits152: Overview on criticality of inputs and factors of differentiation; Exhibits153: Overview on factors of disruption; Exhibits154: Impact of key risks on business; Exhibits155: Companies covered; Exhibits156: Company ranking index; Exhibits157: Matrix on companies position and classification; Exhibits158: AbbVie Inc. - Overview; Exhibits159: AbbVie Inc. - Product / Service; Exhibits160: AbbVie Inc. - Key news; Exhibits161: AbbVie Inc. - Key offerings; Exhibits162: SWOT; Exhibits163: Amgen Inc. - Overview; Exhibits164: Amgen Inc. - Product / Service; Exhibits165: Amgen Inc. - Key news; Exhibits166: Amgen Inc. - Key offerings; Exhibits167: SWOT; Exhibits168: BeiGene Ltd. - Overview; Exhibits169: BeiGene Ltd. - Business segments; Exhibits170: BeiGene Ltd. - Key offerings; Exhibits171: BeiGene Ltd. - Segment focus; Exhibits172: SWOT; Exhibits173: BioMarin Pharmaceutical Inc. - Overview; Exhibits174: BioMarin Pharmaceutical Inc. - Product / Service; Exhibits175: BioMarin Pharmaceutical Inc. - Key offerings; Exhibits176: SWOT; Exhibits177: BioNTech SE - Overview; Exhibits178: BioNTech SE - Product / Service; Exhibits179: BioNTech SE - Key offerings; Exhibits180: SWOT; Exhibits181: F. Hoffmann La Roche Ltd. - Overview; Exhibits182: F. Hoffmann La Roche Ltd. - Business segments; Exhibits183: F. Hoffmann La Roche Ltd. - Key news; Exhibits184: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits185: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits186: SWOT; Exhibits187: Genmab AS - Overview; Exhibits188: Genmab AS - Product / Service; Exhibits189: Genmab AS - Key offerings; Exhibits190: SWOT; Exhibits191: Gilead Sciences Inc. - Overview; Exhibits192: Gilead Sciences Inc. - Product / Service; Exhibits193: Gilead Sciences Inc. - Key news